SelectedWorks - Chad A. Knoderer

Contact

Selected Works of Chad A. Knoderer

Associate Processor of Pharmacy Practice

Chad Knoderer is an Associate Professor of Pharmacy and Director for Clinical and Health Outcomes Research Department of Pharmacy Practice at Butler University.

Works
About

×

About Chad A. Knoderer

Chad Knoderer is an Associate Professor of Pharmacy and Director for Clinical and Health Outcomes Research Department of Pharmacy Practice at Butler University.

Present	Associate Processor, Butler University ‐ Department of Pharmacy Practice
Institution Organization Position Type Position Title Time Period to Options Current Position Affiliate my profile with this Institution
Present	Director for Clinical and Health Outcomes Research, Butler University ‐ Department of Pharmacy Practice
Institution Organization Position Type Position Title Time Period to Options Current Position Affiliate my profile with this Institution

Cancel

Pharmacy and Pharmaceutical Sciences

Pediatric Pharmacology

Academic Leadership Fellows Program- American Association of Colleges of Pharmacy

RX 350 Intro to Pharmaceutical Care
RX 413 Therapeutics 1
RX 500 Introduction to Rotations
RX 527 Biostatistics and Research Design
RX 607 Senior Seminar 1
RX 608 Senior Seminar 2
RX 611-94 Infectious Diseases
RX 641 Pediatric Pharmacotherapy

Articles (33)

Evaluation of an Unfractioned Heparin Pharmacy Dosing Protocol for the ...

Annals of Pharmacotherapy (2017)

Chad A. Knoderer, Lindsey M. Hosch, Emily Y. Breedlove and Lauren E. Scono

Background: Despite large interpatient variability in dose response, heparin is utilized for treatment of venous thromboembolism (VTE). Current data on ...

Occurrence of Potential Adverse Drug Events from Prescribing Errors in ...

Pediatric Drugs (2017)

Chad A. Knoderer, Celeste L. Ewig, Hon Ming Cheung, Kwok Ho Kam, et al.

The pharmacy (organization) divide: A focus on the impact in ...

American Pharmacists Association (2016)

Chad A. Knoderer, Lisa Lubsch and Kristin C. Klein

Optimizing Guideline-Recommended Antibiotic Doses for Pediatric Infective Endocarditis

Annals of Pharmacotherapy (2016)

Chad A. Knoderer, Kristen R. Nichols, Emily N. Israel and Christopher A. Thomas

The American Heart Association recently published an updated scientific statement on the management of infective endocarditis in childhood. The recommendations ...

Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in ...

Antimicrobial Agents and Chemotherapy (2016)

Chad A. Knoderer, Kristen R. Nichols, Eun Kyoung Chung, Lauren E. Buenger, et al.

The study objective was to evaluate the population pharmacokinetics and pharmacodynamics of extended-infusion piperacillintazobactam in children hospitalized in an intensive ...

Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery

Hospital Pharmacy (2015)

Chad A. Knoderer, Hilary M. Teibel and Kristen R. Nichols

Background: Vancomycin and oxacillin may be used together as empiric coverage in patients with proven or suspected Staphylococcus aureus infections. ...

Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric ...

Clinical Pediatrics (2015)

Katelyn E. Brown, Chad A. Knoderer, Kristen R. Nichols and Ashley S. Crumby

Background. Acid-suppressing agents have been associated with increased Clostridium difficile infection (CDI) in adults. The objective of this study was ...

Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery

Hospital Pharmacy (2015)

Hilary M. Teibel, Chad A. Knoderer and Kristen R. Nichols

Background: Vancomycin and oxacillin may be used together as empiric coverage in patients with proven or suspected Staphylococcus aureus infections. ...

Implementing Extended-Infusion Cefepime as Standard of Care in a Children ...

Annals of Pharmacotherapy (2015)

Kristen R. Nichols, Lauren C. Karmire, Elaine G. Cox, Michael B. Kays, et al.

Background: Extended-infusion cefepime (EIC) has been associated with decreased mortality in adults, but to our knowledge, there are no studies ...

Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy

Annals of Pharmacotherapy (2015)

Chad A. Knoderer, Allison L. Gritzman, Kristen R. Nichols and Amy C. Wilson

Background: Acute kidney injury (AKI) in patients receiving vancomycin has been associated with trough concentrations ≥15 mg/L and longer therapy ...

Success With Extended-Infusion Meropenem After Recurrence of Baclofen Pump-Related Achromobacter ...

Journal of Pharmacy Practice (2015)

Kristen R. Nichols, Chad A. Knoderer, Nicholas G. Jackson, John J. Manaloor, et al.

A 13-year-old female experienced a recurrence of baclofen pump-related central nervous system (CNS) infection caused by Achromobacter, despite absence of ...

Are Elevated Vancomycin Serum Trough Concentrations Achieved Within the First ...

Journal of Pediatric Pharmacological Therapy (2014)

Chad A. Knoderer, Kristen R. Nichols, Kelsey C. Lyon, Megan M. Veverka, et al.

Background In 2008, the empiric vancomycin dosing recommendation in children at our institution was changed from 40 to 60 mg/kg ...

Cinacalcet Administration by Gastrostomy Tube in a Child Receiving Peritoneal ...

Journal of Pediatric Pharmacology and Therapy (2014)

Kristen R. Nichols, Chad A. Knoderer, Bethanne Johnston and Amy C. Wilson

A 2-year-old male with chronic kidney disease with secondary hyperparathyroidism developed hypercalcemia while receiving calcitriol, without achieving a serum parathyroid ...

Linezolid-Associated Thrombocytopenia in Children With Renal Impairment

Journal of Pediatrics Infectious Diseases Society (2014)

Sara J. Jones, Kristen R. Nichols, Heather L. DeYoung, Elaine G. Cox, et al.

Impaired renal function has been associated with an increased risk of thrombocytopenia in adults receiving linezolid. Findings from this retrospective ...

Optimized Antimicrobial Dosing Strategies: A Survey of Pediatric Hospitals

Pediatric Drugs (2014)

Chad A. Knoderer, Kristen R. Nichols and Elaine G. Cox

Background Extended-interval aminoglycoside (EIAG) and extended- and continuous-infusion β-lactam (EIBL and CIBL) dosing strategies are increasingly used in adults, but ...

A Randomized, Controlled Trial of Catheter-Related Infectious Event Rates Using ...

Journal of Pediatric Infectious Diseases Society (2013)

Elaine G. Cox, Chad A. Knoderer, Aimee Jennings, John W. Brown, et al.

We conducted a randomized, controlled clinical trial to determine whether a difference in catheter-associated blood stream infection (CABSI) incidence existed ...

Vancomycin and Gentamicin Pharmacokinetic Alterations in an Adolescent Amputee

Journal of Pediatric Pharmacology and Therapy (2013)

Kristen R. Nichols, Kari M. Edison, Michelle D. Rosenbaum and Chad A. Knoderer

A 14-year-old male with bilateral above-the-knee amputations presented to our hospital for treatment of a skin and soft-tissue infection. We ...

Y-Site Compatibility of Vancomycin and Piperacillin/ Tazobactam at Commonly Utilized ...

Hospital Pharmacy (2013)

Kristen R. Nichols, Michael W. DeMarco, Michael D. Vertin and Chad A. Knoderer

Background: Vancomycin and piperacillin/tazobactam are common empiric antibiotics in hospitalized pediatric patients. Studies evaluating intravenous (IV) compatibility at various concentrations ...

Nonsteroidal Anti-Inflammatory Drugs Are an Important Cause of Acute Kidney ...

Journal of Pediatrics (2012)

Jason M. Misurac, Chad A. Knoderer, Jeffrey D. Leiser, Corina Nilescu, et al.

Objective To characterize nonsteroidal anti-inflammatory drug (NSAID)-associated acute kidney injury (AKI) in children. Study design We conducted a retrospective chart ...

System-Wide Implementation of the Use of an Extended-Infusion Piperacillin/Tazobactam ...

Clinical Therapeutics (2012)

Kristen R. Nichols, Chad A. Knoderer and Elaine G. Cox

Background Use of extended infusions of piperacillin/tazobactam (PT) in adult patients has been described, but data in children are limited. ...

Assessment of the Validity of Reported Antibiotic Allergic Reactions in ...

Pharmacotherapy (2011)

Lauren E. Miller, Chad A. Knoderer, Elaine G. Cox and Martin B. Kleinman

Study Objective. To determine whether a reported antibiotic allergy was likely to have been immunologically mediated. Design. Questionnaire-based study. Setting. ...

Assessment of web-based training (WBT) modules on learning facilitation for ...

Journal of Pediatric Pharmacology and Therapy (2011)

Jennifer L. Morris and Chad A. Knoderer

OBJECTIVES: To assess the effectiveness of web-based training (WBT) modules to enhance and facilitate student pharmacists’ learning and their ability ...

Cefepime Neurotoxicity in an Adolescent Cystic Fibrosis Patient with Aminoglycoside-Induced ...

Journal of Pharmaceutical Technology (2011)

Kristen R. Nichols, Danielle M. Brown, Chad A. Knoderer and Sharon P. Andreoli

Objective: To describe a case of cefepime neurotoxicity in an adolescent with cystic fibrosis and aminoglycoside-associated acute kidney injury (AKI). ...

Cefuroxime Pharmacokinetics in Pediatric Cardiovascular Surgery Patients Undergoing Cardiopulmonary Bypass

Journal of Cardiothoracic and Vascular Anesthesia (2011)

Chad A. Knoderer, Sarah A. Saft, Scott G. Walker, Markl D. Rodefeld, et al.

Objectives The objective of this study was to determine the pharmacokinetics of cefuroxime in children undergoing cardiopulmonary bypass (CPB) for ...

Efficacy of Limited Cefuroxime Prophylaxis in Pediatric Patients After Cardiovascular ...

American Journal of Health-System Pharmacy (2011)

Chad A. Knoderer, Elaine G. Cox, Michelle D. Berg, Andrea H. Webster, et al.

Purpose The efficacy of limited cefuroxime prophylaxis in pediatric patients after cardiovascular surgery was evaluated. Methods All patients age 18 ...